GlassScriptPhysician profile
Nitin K Yerram
NPI 1063858595
$82,260.11
in general payments reported to CMS, 2019-2025
20 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2022: $279 · 2023: $18K · 2024: $11K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,850 · Food and Beverage: $3,371 · Travel and Lodging: $3,151 · Honoraria: $2,275 · Education: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,699.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,850.00 |
| Food and Beverage | $3,370.91 |
| Travel and Lodging | $3,150.64 |
| Honoraria | $2,275.00 |
| Education | $1,521.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $62,258.13 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $9,573.81 | 2024-2025 | Adstiladrin |
| Janssen Scientific Affairs, LLC | $3,658.76 | 2024 | |
| Urogen Pharma, INC. | $2,323.50 | 2022-2025 | Jelmyto |
| Intuitive Surgical, INC. | $2,182.42 | 2024 | |
| Janssen Biotech, INC. | $1,379.62 | 2022-2025 | Erleada |
| Boston Scientific Corporation | $399.67 | 2019-2025 | Stone Cone, Ams 700, Axonics |
| Profound Medical Corp. | $165.24 | 2022 | |
| Histosonics, INC. | $65.42 | 2025 | |
| Conmed Corporation | $60.01 | 2025 | Airseal |
| Procept Biorobotics Corporation | $33.42 | 2024 | Aquabeam System |
| Davol INC. | $31.29 | 2023 | Arista Ah Flexitip |
| C. R. Bard, INC. & Subsidiaries | $26.99 | 2023-2024 | Bard Urinary Drainage Bag |
| Mimedx Group, INC. | $24.77 | 2025 | |
| Pfizer INC. | $21.00 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $19.93 | 2025 | |
| Abc Home Medical Supply, INC. | $19.26 | 2025 | |
| Sumitomo Pharma America, INC. | $16.87 | 2023 | Gemtesa |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Yerram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.